Dow Up0.11% Nasdaq Up0.50%

Amicus Therapeutics, Inc. (FOLD)

-NasdaqGM
7.19 0.08(1.10%) Aug 29, 3:59PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 475   456   324   39  
Cost of Revenue -   -   -   -  
Gross Profit 475   456   324   39  
Operating Expenses
Research Development9,978  9,992  9,120  10,110  
Selling General and Administrative4,448  5,681  4,605  4,635  
Non Recurring(81)(8)1,988   -  
Others396  412  401  429  
Total Operating Expenses14,741  16,077  16,114   -  
Operating Income or Loss (14,266) (15,621) (15,790) (15,135)
Income from Continuing Operations
Total Other Income/Expenses Net26  33  61  553  
Earnings Before Interest And Taxes(14,240)(15,588)(15,729)(14,582)
Interest Expense374  355  20  7  
Income Before Tax(14,614)(15,943)(15,749)(14,589)
Income Tax Expense -   -  (3,512) -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(14,614)(15,943)(12,237)(14,589)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (14,614) (15,943) (12,237) (14,589)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (14,614) (15,943) (12,237) (14,589)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.